ArticlePharmaceutics2025

Ferrocene-Based Hybrid Drugs as Potential Anticancer and Antibacterial Therapeutic Agents for Incorporation into Nanocarriers: In Silico, In Vitro, Molecular Docking Evaluations.

Sijongesonke Peter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.